Oncotelic Therapeutics, Inc. (OTLC)
0.036
0.00 (0.00%)
USD |
OTCM |
Apr 28, 16:00
Oncotelic Therapeutics Research and Development Expense (TTM) : 0.0044M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Johnson & Johnson | 14.99B |
| Supernus Pharmaceuticals, Inc. | 104.15M |
| Sarepta Therapeutics, Inc. | 1.516B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |